Compared to cocultures of unmodified NK-92 cells with patient-derived GBM cells, Annexin V was upregulated in GD2+ GBM cells cocultured with modified NK-92 cells harboring either the NFκB-driven EGFP or NFκB-driven IL-12 “all-in-one” vector constructs. The gene discussed is NFKB1; the disease is glioblastoma.